Skip to main content

Table 1 Descriptive summary of study patient demographics and clinical characteristics by Sjögren’s disease status

From: Prediction of Sjögren’s disease diagnosis using matched electronic dental-health record data

Variable

Non-SD Control

(n = 371)

SD Case

(n = 129)

Total

(N = 500)

p-value

Age, mean (std. dev.)

56.2 (16.5)

55.3 (15.8)

56.0 (16.3)

0.231

Gender, n (%)

   

0.996

Female

346 (93.3)

118 (91.5)

464 (92.8)

 

Male

23 (6.2)

11 (8.5)

34 (6.8)

 

Unknown

2 (0.5)

0 (0)

2 (0.4)

 

Race, n (%)

   

0.794

Asian/Pacific Islander

3 (0.8)

2 (1.6)

5 (1.0)

 

Black or African American

70 (18.9)

27 (20.9)

97 (19.4)

 

Multiracial

3 (0.8)

1 (0.8)

4 (0.8)

 

Other/Unknown

6 (1.6)

1 (0.8)

7 (1.4)

 

White

288 (77.6)

98 (76.0)

386 (77.2)

 

American Indian or Alaska Native

1 (0.3)

0 (0)

1 (0.2)

 

Drug Class, n (%)

Antimalarials

4 (1.1)

18 (14.0)

22 (4.4)

7.00E-06

Glucocorticosteroids

59 (15.9)

47 (36.4)

106 (21.2)

1.52E-07

Nonsteroidal Anti-inflammatory Agents (NSAIDs)

88 (23.7)

49 (38.0)

137 (27.4)

0.001

Throat Products - Misc.

3 (0.8)

14 (10.9)

17 (3.4)

2.49E-05

Diagnosis Category, n (%)

    

Depressive disorder

56 (15.1)

42 (32.6)

98 (19.6)

1.77E-05

Diabetes

60 (16.2)

21 (16.3)

81 (16.2)

0.943

Myalgia and myositis/Fibromyalgia

24 (6.5)

36 (27.9)

60 (12.0)

4.13E-08

Pain in joints

73 (19.7)

58 (45.0)

131 (26.2)

3.10E-07

Systemic lupus erythematosus

5 (1.3)

21 (16.3)

26 (5.2)

1.35E-06

Tear Film Insufficiency

5 (1.3)

21 (16.3)

26 (5.2)

3.66E-06

Dental Procedure Category, n (%)

    

Diagnostic

323 (87.1)

107 (82.9)

430 (86.0)

0.239

Surgery

68 (18.3)

45 (34.9)

113 (22.6)

8.40E-05

Laboratory Test: Rheumatoid Factor, n (%)

9 (2.4)

18 (14.0)

27 (5.4)

1.18E-05

Dry Mouth, n (%)

10 (2.7)

38 (29.5)

48 (9.6)

1.70E-10

Dry Eyes, n (%)

0 (0)

12 (9.3)

12 (2.4)

1.99e-08

  1. Std. dev.: Standard deviation; p-values from univariable conditional logistic regression models